<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The small and large intestines are tubular organs composed of several tissue types </plain></SENT>
<SENT sid="1" pm="."><plain>The columnar epithelium that lines the inner surface of the intestines distinguishes the digestive <z:mp ids='MP_0001532'>physiology</z:mp> of each region of the intestine and consists of several distinct cell types that are rapidly and continually renewed by intestinal stem cells that reside near the base of the crypts of Lieberk√ºhn </plain></SENT>
<SENT sid="2" pm="."><plain>Notch signaling controls the fate of intestinal stem cells by regulating the expression of Hes genes and by repressing Atoh1 </plain></SENT>
<SENT sid="3" pm="."><plain>Alternate models of Notch pathway control of cell fate determination are presented </plain></SENT>
<SENT sid="4" pm="."><plain>Roles for Notch signaling in development of the intestine, including mesenchymal and neural cells, are discussed </plain></SENT>
<SENT sid="5" pm="."><plain>The oncogenic activities of Notch in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, as well as the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive activities of Atoh1, are reviewed </plain></SENT>
<SENT sid="6" pm="."><plain>Therapeutic targeting of the Notch pathway in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> is discussed, along with potential caveats </plain></SENT>
</text></document>